| Financial Year |
March 31 2023 |
| Monetary Funds |
3,433,348,764.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,977,621.40 |
| Accounts Receivable |
2,422,526,036.42 |
| Advances to Suppliers |
954,252,213.42 |
| Other Receivables |
533,413,301.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,267,514,002.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
795,024,226.02 |
| Other Current Assets |
1,208,197,231.64 |
| Total Current Assets |
13,547,097,585.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,082,357,871.54 |
| Long-term Equity Investment |
984,953,267.18 |
| Investment Properties |
56,923,482.00 |
| Fixed Assetes |
575,513,754.51 |
| Under-construction Projects |
15,346,243,519.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,274,433,580.07 |
| R&D expenses |
-- |
| Goodwill |
7,363,044.90 |
| Long-Term Deferred and Prepaid Expenses |
151,037,439.10 |
| Deferred Income Tax Assets |
233,622,126.13 |
| Other Non-Current Assets |
2,160,570,010.21 |
| Sub-Total of Non-Current Assets |
38,058,490,481.92 |
| Total Assets |
51,605,588,067.69 |
| Short-Term Loans |
1,029,904,755.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,156,772,872.66 |
| Accounts Payable |
5,665,628,480.56 |
| Accounts Received In Advance |
50,522,895.39 |
| Employee Compensation Payable |
73,590,915.19 |
| Taxes Payable |
366,940,337.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
696,639,139.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,620,500,000.00 |
| Other Current Liabilities |
637,472,744.59 |
| Sub-Total of Current Liabilities |
13,311,277,308.51 |
| Long-term Loans |
29,826,489,020.37 |
| Bonds Payable |
484,832,385.49 |
| Long-Term Accounts Payable |
1,467,973,491.92 |
| Special Payable |
-- |
| Estimatied Liabilities |
498,628,161.72 |
| Deferred Income Tax Liabilities |
1,969,265.70 |
| Other Non-Current Liabilities |
390,000,000.00 |
| Sub-Total of Non-Current Liabilities |
32,715,666,384.86 |
| Total Liabilities |
46,026,943,693.37 |
| Paid-In Capital(Or Share Stock) |
1,268,291,582.00 |
| Capital Surplus |
1,377,597,805.30 |
| Surplus Reserve |
81,300,686.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
623,488,978.11 |
| Minority Stockholder's Interest |
2,147,338,075.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,431,306,298.60 |
| Owner's Equity（Stockholder's Equity） |
5,578,644,374.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
51,605,588,067.69 |
